Data updated: May 26, 2026
LASTACAFT (alcaftadine)
Ophthalmology
Approved 2010-07-28
2
Indications
--
Phase 3 Trials
15
Years on Market
Details
- Status
- Over-the-counter
- First Approved
- 2010-07-28
- Patent Cliff
- 2027
- Routes
- OPHTHALMIC
- Dosage Forms
- SOLUTION/DROPS
LASTACAFT Approval History
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
8 FDA actions from 2010 to 2022 · 1 indication expansions
Aug 2014 SUPPL
Mfg
Jul 2014 SUPPL
Mfg
What LASTACAFT Treats
2 FDA approvalsOriginally approved for its first indication in 2010 . Covers 2 distinct patient populations.
- Other (2)
📋
Clinical Trial Registry
1 trials| Trial | Sponsor ID | Phase | Status | Title |
|---|---|---|---|---|
| NCT00889330 results posted | 09-003-05 | Ph 3 | completed | Safety and Efficacy Study of a Eye Drop for Eye Allergy |
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
|
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
LASTACAFT FDA Label Details
View full patent landscape →
2 OB patents · 1 families ·
61 international docs across 30 countries
LASTACAFT Patents & Exclusivity
Latest Patent: Dec 2027
Patents (2 active)
US8664215
Expires Dec 23, 2027
US10617695
Expires Mar 19, 2027
Source: FDA Orange Book
Pro Intelligence Preview
Deep insights for LASTACAFT
Revenue Insights
- • Quarterly revenue tracking
- • Historical trend analysis
Patent Timeline
- • Cliff: 2027
- • 2 active patents
Trial Analysis
- • Clinical trial tracking
- • Development stage analysis
Competitive Landscape
- • Competitor tracking
- • Same target/indication analysis
Unlock Full Intelligence
Full approval history • All patents • Revenue trends • Competitor analysis
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.